Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction.

ABSTRACT: Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction.

ORGANISM(S): Mus musculus

PROVIDER: GSE231504 | GEO | 2023/05/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction.

Project description:Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction.

| PRJNA966169 | ENA

Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction.

Project description: Not available

| S-EPMC10412436 | biostudies-literature

Limonin ameliorates metabolic dysfunction-associated steatohepatitis in mice

Project description:Limonin (Lim), a triterpenoid predominantly enriched in citrus fruits, exhibits diverse pharmacological activities, yet its therapeutic efficacy and mechanistic basis in metabolic dysfunction-associated steatohepatitis (MASH) remain poorly defined. Here, we show that Lim attenuates liver fibrosis and hepatocellular apoptosis in MASH mouse models induced by a methionine–choline-deficient (MCD) diet.

2026-04-30 | GSE328199 | GEO

Limonin ameliorates metabolic dysfunction-associated steatohepatitis in mice

Project description:Limonin ameliorates metabolic dysfunction-associated steatohepatitis in mice

| PRJNA1454326 | ENA

Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis

Project description:Pathogenesis and factors for determining progression of alcoholic and non-alcoholic steatosis to steatohepatitis with risk of further progression to liver cirrhosis and cancer are poorly understood. In the present study, we aimed to identify potential molecular signatures for discrimination of steatohepatitis from steatosis. Global gene expression analysis was applied to unravel differentially expressed genes between steatohepatitis compared to steatosis and control samples. For functional annotation as well as the identification of disease-relevant biological processes of the differentially expressed genes the gene ontology (GO) database was used. Genes down-regulated in steatohepatitis were mainly involved in metabolic processes. Genes up-regulated in steatohepatitis samples were associated with cancer progression and proliferation. Further statistical and pathway analysis lead to the selection of 46 candidate genes which were validated in two sample cohorts by quantitative real-time PCR. In surgical liver resection samples 39 genes and in percutaneous liver biopsies 30 genes were significantly up-regulated in steatohepatitis. Conclusion: The development of steatohepatitis is characterized by distinct molecular changes. 44 human liver tissue surgical samples (normal n=13; steatosis n=19; steatohepatitis n=12, 8/2 cirrhotic/non-cirrhotic) obtained from patients undergoing liver surgery for HCC, other malignancy/metastatic disease, benign tumors of the liver and organ dedicated to transplantation. Virtually normal control samples in this cohort were taken from patients undergoing surgical resection of liver metastasis, but the surrounding liver tissue used for the molecular analyses was normal, non-tumorous liver tissue without detectable pathological changes. The samples were provided by the Biobank at the Medical University of Graz. This dataset is part of the TransQST collection.

2012-12-10 | E-GEOD-33814 | biostudies-arrayexpress

Silencing of S100A11 Attenuates Murine Metabolic Dysfunction-associated Steatohepatitis

Project description:Silencing of S100A11 Attenuates Murine Metabolic Dysfunction-associated Steatohepatitis

| PRJNA1300449 | ENA

Potential utility of L-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis

Project description:We examined the potential utility of L-carnitine for alleviating metabolic dysfunction-associated steatohepatitis (MASH) and preventing the development of hepatocellular carcinoma. Short-term L-carnitine administration ameliorated MASH through its anti-inflammatory effects.

2024-04-24 | GSE261938 | GEO

Hepatic FoxO3 Supports Metabolic Resilience, Attenuates Age-Associated Obesity and Metabolic Dysfunction, and Mitigates Diet-Induced Steatohepatitis

Project description:Forkhead box O3 (FoxO3) is implicated in aging and metabolic regulation; however, its roles in the local and systemic control of aging remain incompletely understood. In this study, we characterized the effects of hepatocyte-specific Foxo3 deletion on hepatic metabolic and whole-body energy homeostasis during aging, and the susceptibility of mice to metabolic disease. Male hepatocyte-specific Foxo3 knockout (h-Foxo3-/-) mice developed moderate obesity and higher plasma insulin levels by middle age, despite no difference in food intake compared with wild-type mice. Indirect calorimetry revealed lower energy expenditure relative to body weight, a higher respiratory quotient, and less fatty acid oxidation, indicating a shift toward carbohydrate-dependent energy metabolism. Adipose tissue exhibited inflammatory cell infiltration and high expression of inflammatory and senescence markers, consistent with systemic insulin resistance. Although these findings suggested that hepatokine signaling regulates systemic metabolism, there was limited direct evidence for FoxO3-dependent hepatokine secretion. RNA-sequencing analysis suggested that fatty acid processing and xenobiotic and detoxification pathways were suppressed in h-Foxo3-/- liver and that gluconeogenic and proinflammatory programs were activated. h-Foxo3-/- mice exhibited hepatic steatosis and an increase in the oxidized glutathione concentration when consuming a regular diet, and those consuming a fat-, fructose-, and cholesterol-rich diet, which induces steatohepatitis, showed more severe fibrosis than controls. Collectively, these findings suggest that hepatic FoxO3 is a key regulator coordinating hepatic lipid processing, xenobiotic metabolism and detoxification, susceptibility to metabolic disorders, and systemic metabolic flexibility. Thus, hepatic FoxO3 contributes to the maintenance of metabolic resilience during aging.

2026-07-29 | GSE328603 | GEO

ACSS2 aggravates Metabolic dysfunction associated steatohepatitis (MASH) by regulating AIF1 mediated inflammation

Project description:Metabolic dysfunction associated steatohepatitis (MASH) is one of the most common types of liver disease, which is caused by hepatotoxicity caused by metabolic disorder. The incidence rate and mortality are very high, but the current treatment drugs are still limited. The role of ACSS2 in regulating inflammation in MASH is unclear. This study aims to explore the role and potential mechanisms of ACSS2 in the progression of MASH.

2026-06-16 | GSE310314 | GEO

Proteomics data of hepatocytes in metabolism dysfunction associated steatohepatitis.

Project description:In this study, metabolism dysfunction associated steatohepatitis (MASH) hepatocytes and normal hepatocytes were collected from three MASH mouse models and normal diet control fixed-frozen liver sections with laser capture microdissection (LCM), respectively. Protein was processed from these LCM samples using the HDMSP method. LC-MS/MS analysis was performed with Orbitrap Astral mass spectrometer coupled with Vanquish Neo UHPLC system.

2025-09-01 | PXD067929 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data